A Mechanistic Pharmacokinetic/Pharmacodynamic Model for Sequence-Dependent Synergy in Pemetrexed-Osimertinib Combinations Against Non-Small Cell Lung Cancer (NSCLC): Translational Insights.

Pharmaceutics · 2026 · PMC13118741 · PMID 42076061

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although OS data remained immature, a favorable trend was observed.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.